BIIB vs BNTX: stock comparison and AI forecast
Biogen Inc. (BIIB) and Biontech Se (BNTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BIIB Biogen Inc.
- Market Cap
- $36.80B
- P/E Ratio
- 107.3x
- Size
- large-cap
- AI Forecast
BNTX Biontech Se
- Market Cap
- $22.30B
- P/E Ratio
- 2.3x
- Size
- large-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- BIIB is 1.7 times larger than BNTX by market capitalization ($36.80B against $22.30B).
- BNTX trades at 2.3 times trailing earnings, BIIB at 107.3 times.
- BNTX turns 32.0% of its revenue into net income, against 3.4% for BIIB.
- BIIB carries 0.69 times debt per unit of equity, against 0.14 times for BNTX.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BIIB | BNTX |
|---|---|---|
| Market Cap | $36.80B | $22.30B |
| P/E Ratio | 107.30x | 2.28x |
| P/B Ratio | 1.94x | – |
| EPS | $2.32 | $38.67 |
| Book Value/Share | $128.01 | – |
| Revenue/Share | $69.66 | $119.85 |
| FCF/Share | $14.01 | $83.21 |
Profitability & Margins
| Metric | BIIB | BNTX |
|---|---|---|
| ROE | 1.8% | 44.5% |
| ROA | 1.1% | 38.9% |
| ROIC | – | 53.5% |
| Gross Margin | 74.0% | 82.1% |
| Operating Margin | – | 39.7% |
| Net Margin | 3.4% | 32.0% |
| EBT Margin | 4.3% | 46.4% |
| Tax Rate | 21.9% | 31.0% |
Financial Health
| Metric | BIIB | BNTX |
|---|---|---|
| Current Ratio | 1.95x | 7.54x |
| Quick Ratio | 1.37x | 7.49x |
| D/E Ratio | 0.69x | 0.14x |
| Financial Leverage | 1.69x | 1.14x |
| Interest Coverage | 9.2x | – |
| Working Capital | $3.69B | $16.45B |
Cash Flow
| Metric | BIIB | BNTX |
|---|---|---|
| Operating Cash Flow | $2.25B | $22.22B |
| Free Cash Flow | $2.07B | $21.04B |
| Capital Spending | -$176M | -$1.18B |
| OCF Growth YoY | -8.4% | – |
| FCF Growth YoY | -10.1% | 0.0% |
| FCF/Sales | 20.1% | 69.4% |
| CapEx/Sales | 1.7% | 3.9% |
Operational Efficiency
| Metric | BIIB | BNTX |
|---|---|---|
| Asset Turnover | 0.32x | 1.22x |
| Receivables Turnover | – | 28.9x |
| Inventory Turnover | 1.2x | 43.2x |
| Fixed Assets Turnover | 3.5x | 24.8x |
| Days Sales Outstanding | – | 13 days |
| Days Inventory | 303 days | 8 days |
| Payables Period | 59 days | 41 days |
| Cash Conversion Cycle | – | -20 days |
Income Statement
| Metric | BIIB | BNTX |
|---|---|---|
| Total Revenue | $10.30B | $30.31B |
| Operating Income | – | $12.03B |
| Net Income | $348M | $9.70B |
| R&D Expense | $2.15B | $8.70B |
| SG&A Expense | $2.75B | – |
| Cost of Goods Sold | $2.68B | $5.41B |
Dividend & Shareholder Information
| Metric | BIIB | BNTX |
|---|---|---|
| Shares Outstanding | 148M | 253M |
| Net Income Growth | -78.4% | – |
| EPS Growth | -78.8% | – |
BIIB vs BNTX: stock comparison and AI forecast
Which is bigger, BIIB or BNTX?
BIIB is 1.7 times larger than BNTX by market capitalization ($36.80B against $22.30B).
Which is cheaper on earnings, BIIB or BNTX?
BNTX trades at 2.3 times trailing earnings, BIIB at 107.3 times.
Which one does Intratio's AI model rank higher, BIIB or BNTX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.